Infertility following trisomic pregnancies: A nationwide cohort study.

epidemiology infertility maternal age risk factor trisomy

Journal

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics
ISSN: 1879-3479
Titre abrégé: Int J Gynaecol Obstet
Pays: United States
ID NLM: 0210174

Informations de publication

Date de publication:
26 Jul 2024
Historique:
revised: 14 07 2024
received: 06 06 2024
accepted: 15 07 2024
medline: 26 7 2024
pubmed: 26 7 2024
entrez: 26 7 2024
Statut: aheadofprint

Résumé

To study whether gynecologic or reproductive disorders show association with trisomic conceptions. This nationwide cohort study utilized the Registry of Congenital Malformations to identify women who had a trisomic pregnancy (n = 5784), either with trisomy 13 (T13; n = 351), trisomy 18 (T18; n = 1065) or trisomy 21 (T21; n = 4369) from 1987 to 2018. We used the Finnish Maternity cohort to match the cases to population controls (n = 34 422) on the age, residence, and timing of pregnancy. These data were cross-linked to the ICD-10 diagnoses of the national Care Registry for Health Care data on specialized health care in Finland during 1996 to 2019. Both inflammatory (ICD-10 diagnoses: N70-N77) and noninflammatory disorders of the genital tract (N80-N98) were studied. Crude odds ratios (ORs) with 95% CIs were calculated for associations between diagnoses and trisomic conceptions. The diagnosis of female infertility (N97) at any time was associated with trisomic conceptions (OR: 1.19, 95% CI: 1.08-1.32). In the subgroup analysis, this association was found for T18 (OR: 1.29, 95% CI: 1.03-1.61) and T21 (OR: 1.17, 95% CI: 1.04-1.32), but not for T13 (OR: 1.15, 95% CI: 0.75-1.72). When restricting the timing of the diagnosis of female infertility, an elevated OR was found only after the index pregnancy (OR: 1.81, 95% CI: 1.56-2.09). These increased odds for infertility after trisomic conceptions were observed both in women <35 years (T18 OR: 1.91, 95% CI: 1.21-3.00; T21 OR: 1.68, 95% CI: 1.31-2.14) and in women ≥35 years (T18 OR: 2.17, 95% CI: 1.40-3.33; T21 OR: 1.87; 95% CI: 1.47-2.39), but not after T13 conceptions. Our observational data suggest a link between trisomic conceptions and subsequent diagnoses of infertility but do not demonstrate causality. These data implicate that partially similar mechanisms might predispose to trisomy and infertility, regardless of maternal age.

Identifiants

pubmed: 39056516
doi: 10.1002/ijgo.15828
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Päivikki ja Sakari Sohlbergin Säätiö
Organisme : Juhani Ahon Lääketieteen Tutkimussäätiö

Informations de copyright

© 2024 The Author(s). International Journal of Gynecology & Obstetrics published by John Wiley & Sons Ltd on behalf of International Federation of Gynecology and Obstetrics.

Références

Hassold TJ, Jacobs PA. Trisomy in man. Annu Rev Genet. 1984;18:69‐97.
Gruhn JR, Zielinska AP, Shukla V, et al. Chromosome errors in human eggs shape natural fertility over reproductive life span. Science. 2019;365:1466‐1469.
Hassold T, Hunt P. To err (meiotically) is human: the genesis of human aneuploidy. Nat Rev Genet. 2001;2:280‐291.
Elmerdahl Frederiksen L, Ølgaard SM, Roos L, et al. Maternal age and the risk of fetal aneuploidy: a nationwide cohort study of more than 500 000 singleton pregnancies in Denmark from 2008 to 2017. Acta Obstet Gynecol Scand. 2024;103:351‐359.
Fragouli E, Alfarawati S, Spath K, et al. The origin and impact of embryonic aneuploidy. Hum Genet. 2013;132:1001‐1013.
Herbert M, Kalleas D, Cooney D, Lamb M, Lister L. Meiosis and maternal aging: insights from aneuploid oocytes and trisomy births. Cold Spring Harb Perspect Biol. 2015;7:a017970.
Hassold T, Chiu D. Maternal age‐specific rates of numerical chromosome abnormalities with special reference to trisomy. Hum Genet. 1985;70:11‐17.
Nagaoka SI, Hassold TJ, Hunt PA. Human aneuploidy: mechanisms and new insights into an age‐old problem. Nat Rev Genet. 2012;13:493‐504.
Lamb NE, Sherman SL, Hassold TJ. Effect of meiotic recombination on the production of aneuploid gametes in humans. Cytogenet Genome Res. 2005;111:250‐255.
Coppedè F. Risk factors for down syndrome. Arch Toxicol. 2016;90:2917‐2929.
Antonarakis SE, Skotko BG, Rafii MS, et al. Down syndrome. Nat Rev Dis Primers. 2020;6:9.
Cuckle H, Benn P. Review of epidemiological factors (other than maternal age) that determine the prevalence of common autosomal trisomies. Prenat Diagn. 2021;41:536‐544.
Gianaroli L, Magli MC, Cavallini G, et al. Predicting aneuploidy in human oocytes: key factors which affect the meiotic process. Hum Reprod. 2010;25:2374‐2386.
Shahine LK, Marshall L, Lamb JD, Hickok LR. Higher rates of aneuploidy in blastocysts and higher risk of no embryo transfer in recurrent pregnancy loss patients with diminished ovarian reserve undergoing in vitro fertilization. Fertil Steril. 2016;106:1124‐1128.
Warburton D, Dallaire L, Thangavelu M, Ross L, Levin B, Kline J. Trisomy recurrence: a reconsideration based on North American data. Am J Hum Genet. 2004;75:376‐385.
Weghofer A, Munne S, Chen S, Barad D, Gleicher N. Lack of association between polycystic ovary syndrome and embryonic aneuploidy. Fertil Steril. 2007;88:900‐905.
Mansour G, Sharma RK, Agarwal A, Falcone T. Endometriosis‐induced alterations in mouse metaphase II oocyte microtubules and chromosomal alignment: a possible cause of infertility. Fertil Steril. 2010;94:1894‐1899.
Juneau C, Kraus E, Werner M, et al. Patients with endometriosis have aneuploidy rates equivalent to their age‐matched peers in the in vitro fertilization population. Fertil Steril. 2017;108:284‐288.
Yan N, Yuan X, Huang S, Jie H, Wang J, Yuan Y. Ovarian endometrioma increases the embryo aneuploid rate: an analysis of 7092 biopsied blastocysts from fertile monogenetic disease carriers. BMC Womens Health. 2023;23:244.
Gissler M, Surcel HM. Combining health register data and biobank data. Stat J IAOS. 2012;28:53‐58.
Hassold T, Hunt P. Maternal age and chromosomally abnormal pregnancies: what we know and what we wish we knew. Curr Opin Pediatr. 2009;21:703‐708.
Savva GM, Morris JK, Mutton DE, Alberman E. Maternal age‐specific fetal loss rates in Down syndrome pregnancies. Prenat Diagn. 2006;26:499‐504.
Bray IC, Wright DE. Estimating the spontaneous loss of Down syndrome fetuses between the times of chorionic villus sampling, amniocentesis and livebirth. Prenat Diagn. 1998;18:1045‐1054.
Atrash HK, Hogue CJ. The effect of pregnancy termination on future reproduction. Baillieres Clin Obstet Gynaecol. 1990;4:391‐405.
Thorp JM Jr, Hartmann KE, Shadigian E. Long‐term physical and psychological health consequences of induced abortion: review of the evidence. Obstet Gynecol Surv. 2003;58:67‐79.
Witters G, Van Robays J, Willekes C, et al. Trisomy 13, 18, 21, Triploidy and Turner syndrome: the 5T's. Look at the hands. Facts Views Vis Obgyn. 2011;3:15‐21.
Morin SJ, Eccles J, Iturriaga A, Zimmerman RS. Translocations, inversions and other chromosome rearrangements. Fertil Steril. 2017;107:19‐26.
Sharma R, Biedenharn KR, Fedor JM, Agarwal A. Lifestyle factors and reproductive health: taking control of your fertility. Reprod Biol Endocrinol. 2013;11:66.
Malin M, Hemminki E, Räikkönen O, Sihvo S, Perälä ML. What do women want? Women's experiences of infertility treatment. Soc Sci Med. 2001;53:123‐133.
Terävä AN, Gissler M, Hemminki E, Luoto R. Infertility and the use of infertility treatments in Finland: prevalence and socio‐demographic determinants 1992‐2004. Eur J Obstet Gynecol Reprod Biol. 2008;136:61‐66.
Charalambous C, Webster A, Schuh M. Aneuploidy in mammalian oocytes and the impact of maternal ageing. Nat Rev Mol Cell Biol. 2023;24:27‐44.
Kort JD, McCoy RC, Demko Z, et al. Are blastocyst aneuploidy rates different between fertile and infertile populations? J Assist Reprod Genet. 2018;35:403‐408.
Munné S, Sandalinas M, Magli C, Gianaroli L, Cohen J, Warburton D. Increased rate of aneuploid embryos in young women with previous aneuploid conceptions. Prenat Diagn. 2004;24:638‐643.
Oliver TR, Feingold E, Yu K, et al. New insights into human nondisjunction of chromosome 21 in oocytes. PLoS Genet. 2008;4:e1000033.
Chernus JM, Allen EG, Zeng Z, et al. A candidate gene analysis and GWAS for genes associated with maternal nondisjunction of chromosome 21. PLoS Genet. 2019;15:e1008414.
Antonarakis SE, Avramopoulos D, Blouin JL, Conover Talbot C Jr, Schinzel AA. Mitotic errors in somatic cells cause trisomy 21 in about 4.5% of cases and are not associated with advanced maternal age. Nat Genet. 1993;3:146‐150.
Warburton D. The effect of maternal age on the frequency of trisomy: change in meiosis or in utero selection? Prog Clin Biol Res. 1989;311:165‐181.

Auteurs

Satu Wedenoja (S)

Information Brokers, Finnish Institute for Health and Welfare, Helsinki, Finland.
Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Stem Cells and Metabolism Research Program, University of Helsinki, Helsinki, Finland.
Folkhälsan Research Center, Helsinki, Finland.

Mika Pihlajamäki (M)

Information Brokers, Finnish Institute for Health and Welfare, Helsinki, Finland.

Mika Gissler (M)

Information Brokers, Finnish Institute for Health and Welfare, Helsinki, Finland.
Research Center for Child Psychiatry, University of Turku, Turku, Finland.
Region Stockholm, Academic Primary Health Care Center, Stockholm, Sweden.
Karolinska Institutet, Department of Molecular Medicine and Surgery, Stockholm, Sweden.

Juho Wedenoja (J)

Department of Ophthalmology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

Hanna Öhman (H)

Biobank Borealis of Northern Finland, Oulu University Hospital, Oulu, Finland.
Faculty of Medicine, University of Oulu, Oulu, Finland.

Seppo Heinonen (S)

Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

Juha Kere (J)

Stem Cells and Metabolism Research Program, University of Helsinki, Helsinki, Finland.
Folkhälsan Research Center, Helsinki, Finland.
Department of Biosciences and Nutrition, Karolinska Institutet, Huddinge, Sweden.

Helena Kääriäinen (H)

Genomics and Biomarkers Unit, National Institute for Health and Welfare, Helsinki, Finland.

Laura Tanner (L)

Department of Clinical Genetics, Helsinki University Hospital, Helsinki, Finland.
Department of Medical and Clinical Genetics, University of Helsinki, Helsinki, Finland.

Classifications MeSH